Goldman Jonathan - Insider Non-Derivative Transactions at Avalo Therapeutics, Inc. (AVTX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 14, 2025, Goldman Jonathan's relationship to Avalo Therapeutics, Inc. (AVTX) is Director, and currently has 8,200 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AVTX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Goldman Jonathan - Insider Non-Derivative Transactions of AVTX Common Stock

Goldman Jonathan - Insider Non-Derivative Transactions at AVTX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 15, 2025	Sell -- (Common Stock)	8200	14.35	0
Nov 15, 2025	Sell -- (Common Stock)	3167	14.3	0
Nov 15, 2025	M -- (Common Stock)	8200	9.88	8200
Mar 29, 2025	M -- (Common Stock)	3167	0	3167